Craft

Medicon Hellas

Stock Price

€2.3

2024-10-29

Market Capitalization

€10.2 M

2024-10-29

Revenue

€15.9 M

FY, 2024

Medicon Hellas Summary

Company Summary

Overview
Medicon Hellas engages in the research and development, production, and sale of diagnostic reagent kits. It offers produces instrument-specific and barcoded vial reagents for various analyzers, such as clinical chemistry, specific protein, control and calibration, test, and hematology materials, as well as mega kits for diagnostic labs. The Company also distributes analytical workstations for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems under the MLR name; and vitro diagnostics and lab automation systems.
Type
Public
Status
Active
Founded
1978
HQ
Athens, GR | view all locations
Website
https://www.mediconsa.com/en/
Cybersecurity rating
Sectors

Key People

  • Spiros Dimotsantos

    Spiros Dimotsantos, Chairman, CEO, Founder & President

  • Sotiria Mitropoulou, Director

    • Georgios Dimotsantos
    • Vasilios Loumiotis, Director

      LocationsView all

      1 location detected

      • Athens HQ

        Greece

        5-7 Melitona Street

      Medicon Hellas Financials

      Summary Financials

      Revenue (H1, 2025)
      €8.8M
      Gross profit (H1, 2025)
      €6.4M
      Net income (H1, 2025)
      €797.0K
      Cash (H1, 2025)
      €5.0M
      EBIT (H1, 2025)
      €894.0K
      Enterprise value
      $14.6M

      Footer menu